CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 1,171 enrolled
Drug / intervention
narafilcon B daily disposable soft contact lenses +1 moredevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT01467557
NCT01467557N/ACompleted
CompareCT.gov

1•DAY ACUVUE® TruEye™ Brand Contact Lenses & 1•DAY ACUVUE® MOIST® Brand Contact Lenses With LACREON® TECHNOLOGY Daily Disposable Performance Overview Registry -TEMPO Study

Johnson & Johnson Vision Care, Inc.·observational·Posted Nov 8, 2011·Updated Jun 19, 2018

In Brief

An observational study evaluating narafilcon B daily disposable soft contact lenses and etafilcon A daily disposable soft contact lenses for Myopia and Hyperopia. Completed, enrolled 1,171 participants across 37 sites.

Detailed Summary

This study is an observational registry of patients who have recently been prescribed 1•DAY ACUVUE® TruEye® or 1•DAY ACUVUE® MOIST® Brand Contact Lenses with LACREON® TECHNOLOGY.

Study Details

Study Typeobservational
Allocation--
Masking--
Primary Purpose--
ConditionsMyopia, Hyperopia
CountriesUnited States
Collaborators--

Timeline

N/ACompletedFinished
201220132014201520162017201820192020202120222023202420252026
First PostedNov 8, 2011
Enrollment StartOct 1, 2011
Primary CompletionOct 1, 2013
TodayJul 2, 2026
Enrollment to primary: 2 yearsPosted 14.7 years ago

Interventions

narafilcon B daily disposable soft contact lensesdevice

daily disposable soft contact lenses

etafilcon A daily disposable soft contact lensesdevice

daily disposable soft contact lenses